LUPIN
Lupin Limited
Healthcare
Share price
₹2,029
Market cap
₹93,059 Cr
1Y return
▲ 6%
An innovation-led pharmaceutical company headquartered in Mumbai, Lupin develops and commercializes a broad range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The company operates as a transnational enterprise, serving customers across more than 100 markets including the United States, India, South Africa, Asia Pacific, Latin America, Europe, and the Middle East regions.
Investors holding Lupin Limited
Recent moves 7
ICICI Prudential Mutual FundExited
ICICI Prudential Mutual Fund, which previously held a 1.45 percent stake in Lupin Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete sale or a reduction in its holding to below the 1 percent reporting requirement.
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund trimmed its Lupin Limited stake from 1.83% to 1.74%, selling 406,904 shares.
Read more
Nippon India Mutual FundDecreased
Nippon India Mutual Fund decreased its stake in Lupin Limited from 2.75% to 2.60%, selling 690,361 shares worth ₹166.19 crore.
Read more
HDFC Life InsuranceDecreased
HDFC Life Insurance decreased its stake in Lupin Limited from 1.30% to 1.10%, selling 921,491 shares. The value of the sold shares was approximately ₹222.06 crore at a price of ₹2406.90 per share.
Read more
LICIncreased
LIC increased its stake in Lupin Limited from 2.79% to 4.09%, acquiring 5,953,734 additional shares for ₹1,437.08 crore at ₹2406.90 apiece.
Read more
SBI Mutual FundIncreased
SBI Mutual Fund increased its stake in Lupin Limited from 1.87% to 1.96%, acquiring 424,577 additional shares. The value of the shares purchased is approximately ₹102.16 crore, based on Lupin's share price of ₹2406.90.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Lupin Limited from 4.58% to 4.37%, selling 9,44,779 shares worth ₹227.49 Cr.
Read more